Grant: CIHR Fellowship
Direct Payment
$150,000.00
Metabolic Role of Nrf2 in Obesity and Type 2 Diabetes
EF 2010-11
Résumé
Type 2 diabetes mellitus (T2D) affects millions of Canadians by causing debilitating conditions such as blindness, kidney failure and cardiovascular disease, yet the means of its cure remains unknown. T2D is often linked to obesity. However, it is not obesity per se that causes T2D but an insufficient adaptation of metabolic systems to chronic obesity that result in T2D by causing insulin resistance and beta-cell dysfunction. An understanding of how metabolic adaptations go awry in chronic obesity may reveal a means to reverse this worsening epidemic.
In metabolic tissues, the endoplasmic reticulum (ER) plays a central role in sensing and coordinating responses to obesity via signalling branches collectively known as the unfolded protein response (UPR). During ER stress, the UPR relays messages to various cellular centres to generate responses that restore homeostasis. However, when ER stress is chronic and excessive such as in chronic obesity, the UPR relays a different message that impairs cell function and worsens the metabolic state. These differential relays remain obscure but revealing its nature may identify a means for its manipulation to restore metabolic systems in chronic obesity and T2D. For our studies, we propose to investigate the molecular interface from which the ER coordinates stress responses to obesity. Our hypothesis is that a nuclear receptor linked to ER stress, called Nrf2, functions to moderate ER stress in obesity, thereby preventing the build-up in ER stress that leads to T2D. To test this, we will 1) utilize gain- and loss-of-function models of Nrf2 to examine its role in metabolic systems, ER stress and T2D development in obese mice, 2) characterize the mechanistic links between ER stress and Nrf2 function, and 3) determine the anti-diabetic potential of Nrf2 activators. Overall, these studies will interrogate the metabolic role of Nrf2 in ER stress and chronic obesity, and may reveal Nrf2 as a promising drug target for T2D
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
214464
Name
Widenmaier Scott
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Metabolic Role of Nrf2 in Obesity and Type 2 Diabetes
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biochemistry; Cell And Molecular Biology; Er Stress And Signalling Mechanisms; Genetic And Dietary Mouse Models; Glucose Tolerance; Inflammation And Lipid Mediators; Insulin Action And Beta Cell Function; Obesity And Type 2 Diabetes; Physiology And Metabolic Systems
Abstract
Type 2 diabetes mellitus (T2D) affects millions of Canadians by causing debilitating conditions such as blindness, kidney failure and cardiovascular disease, yet the means of its cure remains unknown. T2D is often linked to obesity. However, it is not obesity per se that causes T2D but an insufficient adaptation of metabolic systems to chronic obesity that result in T2D by causing insulin resistance and beta-cell dysfunction. An understanding of how metabolic adaptations go awry in chronic obesity may reveal a means to reverse this worsening epidemic.
In metabolic tissues, the endoplasmic reticulum (ER) plays a central role in sensing and coordinating responses to obesity via signalling branches collectively known as the unfolded protein response (UPR). During ER stress, the UPR relays messages to various cellular centres to generate responses that restore homeostasis. However, when ER stress is chronic and excessive such as in chronic obesity, the UPR relays a different message that impairs cell function and worsens the metabolic state. These differential relays remain obscure but revealing its nature may identify a means for its manipulation to restore metabolic systems in chronic obesity and T2D. For our studies, we propose to investigate the molecular interface from which the ER coordinates stress responses to obesity. Our hypothesis is that a nuclear receptor linked to ER stress, called Nrf2, functions to moderate ER stress in obesity, thereby preventing the build-up in ER stress that leads to T2D. To test this, we will 1) utilize gain- and loss-of-function models of Nrf2 to examine its role in metabolic systems, ER stress and T2D development in obese mice, 2) characterize the mechanistic links between ER stress and Nrf2 function, and 3) determine the anti-diabetic potential of Nrf2 activators. Overall, these studies will interrogate the metabolic role of Nrf2 in ER stress and chronic obesity, and may reveal Nrf2 as a promising drug target for T2D
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Widenmaier, Scott
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~